Meyka Pro banner
Oneview Healthcare PLC

Oneview Healthcare PLC Fundamental Analysis (ASX: ONE.AX)

ONE.AXASX
HealthcareMedical - Healthcare Information Services
$0.17
$0.00(0.00%)
Australian Market opens in 0h 48m

Oneview Healthcare PLC Fundamental Analysis (ASX: ONE.AX)

Oneview Healthcare PLC (ASX: ONE.AX) shows moderate financial fundamentals with a PE ratio of -8.22, profit margin of -91.45%, and ROE of -2.04%. The company generates $0.0B in annual revenue with strong year-over-year growth of 20.58%.

Key Strengths

PEG Ratio-0.30
Current Ratio1.80

Areas of Concern

ROE-2.04%
Operating Margin-92.62%
We analyze ONE.AX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -224.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-224.8/100

We analyze ONE.AX's fundamental strength across five key dimensions:

Efficiency Score

Weak

ONE.AX struggles to generate sufficient returns from assets.

ROA > 10%
-67.08%

Valuation Score

Excellent

ONE.AX trades at attractive valuation levels.

PE < 25
-8.22
PEG Ratio < 2
-0.30

Growth Score

Excellent

ONE.AX delivers strong and consistent growth momentum.

Revenue Growth > 5%
20.58%
EPS Growth > 10%
18.00%

Financial Health Score

Excellent

ONE.AX maintains a strong and stable balance sheet.

Debt/Equity < 1
0.16
Current Ratio > 1
1.80

Profitability Score

Weak

ONE.AX struggles to sustain strong margins.

ROE > 15%
-203.69%
Net Margin ≥ 15%
-91.45%
Positive Free Cash Flow
No

Key Financial Metrics

Is ONE.AX Expensive or Cheap?

P/E Ratio

ONE.AX trades at -8.22 times earnings. This suggests potential undervaluation.

-8.22

PEG Ratio

When adjusting for growth, ONE.AX's PEG of -0.30 indicates potential undervaluation.

-0.30

Price to Book

The market values Oneview Healthcare PLC at 13.65 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

13.65

EV/EBITDA

Enterprise value stands at -9.73 times EBITDA. This is generally considered low.

-9.73

How Well Does ONE.AX Make Money?

Net Profit Margin

For every $100 in sales, Oneview Healthcare PLC keeps $-91.45 as profit after all expenses.

-91.45%

Operating Margin

Core operations generate -92.62 in profit for every $100 in revenue, before interest and taxes.

-92.62%

ROE

Management delivers $-2.04 in profit for every $100 of shareholder equity.

-2.04%

ROA

Oneview Healthcare PLC generates $-67.08 in profit for every $100 in assets, demonstrating efficient asset deployment.

-67.08%

Following the Money - Real Cash Generation

Operating Cash Flow

Oneview Healthcare PLC generates limited operating cash flow of $-8.27M, signaling weaker underlying cash strength.

$-8.27M

Free Cash Flow

Oneview Healthcare PLC generates weak or negative free cash flow of $-3.99M, restricting financial flexibility.

$-3.99M

FCF Per Share

Each share generates $-0.00 in free cash annually.

$-0.00

FCF Yield

ONE.AX converts -4.10% of its market value into free cash.

-4.10%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-8.22

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.30

vs 25 benchmark

P/B Ratio

Price to book value ratio

13.65

vs 25 benchmark

P/S Ratio

Price to sales ratio

8.24

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.16

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.80

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-2.04

vs 25 benchmark

ROA

Return on assets percentage

-0.67

vs 25 benchmark

ROCE

Return on capital employed

-1.28

vs 25 benchmark

How ONE.AX Stacks Against Its Sector Peers

MetricONE.AX ValueSector AveragePerformance
P/E Ratio-8.2231.40 Better (Cheaper)
ROE-203.69%524.00% Weak
Net Margin-91.45%21470.00% Weak
Debt/Equity0.160.53 Strong (Low Leverage)
Current Ratio1.805.62 Neutral
ROA-67.08%-202.00% (disorted) Weak

ONE.AX outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Oneview Healthcare PLC's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-59.11%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

67.78%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

73.68%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ